Your browser doesn't support javascript.
loading
Major Adverse Cardiac Events With Immune Checkpoint Inhibitors: A Pooled Analysis of Trials Sponsored by the National Cancer Institute-Cancer Therapy Evaluation Program.
Naqash, Abdul Rafeh; Moey, Melissa Y Y; Cherie Tan, Xiao-Wei; Laharwal, Mehak; Hill, Vanessa; Moka, Nagabhishek; Finnigan, Shanda; Murray, James; Johnson, Douglas B; Moslehi, Javid J; Sharon, Elad.
Afiliación
  • Naqash AR; Developmental Therapeutics Clinic, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
  • Moey MYY; Medical Oncology/TSET Phase 1 Program, Stephenson Cancer Center, University of Oklahoma, Oklahoma City, OK.
  • Cherie Tan XW; Department of Cardiovascular Sciences, Vidant Medical Center/East Carolina University, Greenville, NC.
  • Laharwal M; Department of Hematology-Oncology, The University of Maryland Marlene and Stewart Greenbaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD.
  • Hill V; Internal Medicine, Barnabas Health, Livingston, NJ.
  • Moka N; Department of Molecular, Cellular, and Developmental Biology, University of California Santa Barbara, Santa Barbara, CA.
  • Finnigan S; Appalachian Regional Healthcare Cancer Center, Hazard, KY.
  • Murray J; Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Johnson DB; Technical Resources International, Inc, Bethesda, MD.
  • Moslehi JJ; Division of Medical Oncology, Vanderbilt-Ingram Cancer Center, Nashville, TN.
  • Sharon E; Section of Cardio-Oncology & Immunology, Division of Cardiology and the Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA.
J Clin Oncol ; 40(29): 3439-3452, 2022 10 10.
Article en En | MEDLINE | ID: mdl-35658474
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antineoplásicos Inmunológicos / Miocarditis / Neoplasias Tipo de estudio: Evaluation_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: J Clin Oncol Año: 2022 Tipo del documento: Article País de afiliación: Moldova Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antineoplásicos Inmunológicos / Miocarditis / Neoplasias Tipo de estudio: Evaluation_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: J Clin Oncol Año: 2022 Tipo del documento: Article País de afiliación: Moldova Pais de publicación: Estados Unidos